Dextrans
"Dextrans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
Descriptor ID |
D003911
|
MeSH Number(s) |
D05.750.078.562.272 D09.698.365.272
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dextrans".
Below are MeSH descriptors whose meaning is more specific than "Dextrans".
This graph shows the total number of publications written about "Dextrans" by people in this website by year, and whether "Dextrans" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 0 | 1 | 1 | 1983 | 0 | 1 | 1 | 1999 | 1 | 0 | 1 | 2000 | 0 | 1 | 1 | 2002 | 0 | 1 | 1 | 2003 | 0 | 2 | 2 | 2004 | 1 | 0 | 1 | 2005 | 0 | 2 | 2 | 2006 | 2 | 0 | 2 | 2007 | 2 | 0 | 2 | 2008 | 1 | 0 | 1 | 2009 | 2 | 0 | 2 | 2010 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2015 | 0 | 1 | 1 | 2016 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dextrans" by people in Profiles.
-
Saric A, Grinstein S, Freeman SA. Measurement of Autolysosomal pH by Dual-Wavelength Ratio Imaging. Methods Enzymol. 2017; 588:15-29.
-
Canton J, Grinstein S. Measuring lysosomal pH by fluorescence microscopy. Methods Cell Biol. 2015; 126:85-99.
-
Gazdzinski LM, Nieman BJ. Cellular imaging and texture analysis distinguish differences in cellular dynamics in mouse brain tumors. Magn Reson Med. 2014 Apr; 71(4):1531-41.
-
Zamilpa I, Koyle MA, Grady RW, Joyner BD, Shnorhavorian M, Lendvay TS. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy? J Urol. 2011 Jun; 185(6 Suppl):2536-41.
-
Sorensen MD, Koyle MA, Cowan CA, Zamilpa I, Shnorhavorian M, Lendvay TS. Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux. Pediatr Surg Int. 2010 May; 26(5):509-13.
-
Lorenzo AJ. Editorial comment. J Urol. 2009 Sep; 182(3):1157.
-
Vemulakonda VM, Koyle MA, Lendvay TS, Risk MC, Kirsch AJ, Cheng EY, Cisek LJ, Campbell JB. Endoscopic treatment of symptomatic refluxing renal transplant ureteroneocystostomies in children. Pediatr Transplant. 2010 Mar; 14(2):212-5.
-
Dave S, Lorenzo AJ, Khoury AE, Braga LH, Skeldon SJ, Suoub M, Farhat W, Pippi Salle JL, Bägli DJ. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. J Urol. 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600.
-
Higham-Kessler J, Reinert SE, Snodgrass WT, Hensle TW, Koyle MA, Hurwitz RS, Cendron M, Diamond DA, Caldamone AA. A review of failures of endoscopic treatment of vesicoureteral reflux with dextranomer microspheres. J Urol. 2007 Feb; 177(2):710-4; discussion 714-5.
-
Kitchens DM, Minevich E, DeFoor WR, Reddy PP, Wacksman J, Koyle MA, Sheldon CA. Incontinence following bladder neck reconstruction--is there a role for endoscopic management? J Urol. 2007 Jan; 177(1):302-5; discussion 305-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|